Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

Abstract

Statin therapy may be effective in the primary prevention of coronary events among subjects with relatively low lipid levels but with elevated levels of C-reactive protein.

Keywords

LovastatinMedicineC-reactive proteinHyperlipidemiaStatinInternal medicineCholesterolEndocrinologyLipoproteinCardiologyGastroenterologyInflammationDiabetes mellitus

Affiliated Institutions

Related Publications

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Donna K. Arnett , Roger S. Blumenthal , Michelle A. Albert +15 more

1. The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life. 2. A team-based ...

2019 Circulation 4477 citations

Vitamin D Deficiency and Risk of Cardiovascular Disease

Thomas J. Wang , Michael J. Pencina , Sarah L. Booth +7 more

Background— Vitamin D receptors have a broad tissue distribution that includes vascular smooth muscle, endothelium, and cardiomyocytes. A growing body of evidence suggests that ...

2008 Circulation 2359 citations

Non‐alcoholic steatohepatitis: Definitions and pathogenesis

CP Day , S SAKSENA

The term 'non-alcoholic steatohepatitis' or NASH was first used by Ludwig et al. in 1980 to describe 'the pathological and clinical features of non-alcoholic disease of the live...

2002 Journal of Gastroenterology and Hepat... 187 citations

Publication Info

Year: 2001
Type: article
Volume: 344
Issue: 26
Pages: 1959-1965
Citations: 1545
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1545

OpenAlex

Cite This

APA Style

                            
                                
                                    Paul M. Ridker, 
                                
                                    Nader Rifai, 
                                
                                    Michael Clearfield
                                
                                et al.
                            
                            (2001). 
                            Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events. 
                            New England Journal of Medicine
                            , 344
                            (26)
                            , 1959-1965.
                            https://doi.org/10.1056/nejm200106283442601
                        

Identifiers

DOI: 10.1056/nejm200106283442601